Rapamycin is a bacterial compound with anti-fungal, anti-cancer, and immunosuppressive properties, and thus, its target molecule, mTOR (mammalian/mechanistic target of rapamycin) has been implicated in processes such as aging, autophagy, and immune responses (Iglesias-Bartolome et al., 2012; Saxton and Sabatini, 2017) along with cellular pathways of proliferation, transcription, and translation (Shafei et al., 2017). The gene discussed is MTOR; the disease is cancer.